PD Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency HDB Q1 2026 Earnings Solid EPS Beat Amid Steady Operational Performance Amphastar Pharmaceuticals AMPH Q1 2026 Earnings EPS Misses Estimates by Wide Margin IPM Q1 2026 Earnings Significant EPS Miss Reflects Persistent Headwinds KALA Q4 2025 Earnings Loss Narrows Sharply on Disciplined Cost Management ACB Q1 2026 Earnings EPS Misses Estimates by Wide Margin Shares Decline